Effect of serum gamma-glutamyltransferase and obesity on the risk of dyslipidemia and poor glycemic control in type 2 diabetic patients: Cross-sectional findings from the Verona diabetes study [3]

Clinical Chemistry

Volumn 53, Issue 10, 2007, Pages 1867-1869

  Targher, Giovanni ^a,c   Zoppini, Giacomo ^a   Lippi, Giuseppe ^b   Guidi, Gian Cesare ^b   Muggeo, Michele ^a  

^a Section of Endocrinology   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; BODY MASS; COMORBIDITY; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PREVALENCE;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; MALE; OBESITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; SERUM;

EID: 34848921500     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.092601     Document Type: Letter

References (5)

1. Lim JS, Lee OH, Park JY, Jin SH, Jacobs DR Jr. A strong interaction between serum γ-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 2007:53:1092-8.
2. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000;23:45-50.
3. American Diabetes Association. Standard of medical cares in diabetes. Diabetes Care 2007;30(Suppl 1):S4-41.
4. Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease [Review]. Atherosclerosis 2007;191:235-40.
5. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the Third National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1638-44.